Concizumab promotes haemostasis via a tissue factor-factor VIIa-dependent mechanism supporting prophylactic treatment of haemophilia: Results from a rabbit haemophilia bleeding model.

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2019)

Keyphrases